How has CalAmp's operating lease right-of-use asset amortization changed year-over-year?

CalAmp's operating lease right-of-use asset amortization decreased by 92.8% year-over-year, from $475K to $34K.

CalAmp CAMP Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Ionis PharmaceuticalsIONS

——

Rapport Therapeutics, Inc.RAPP

——

Taysha Gene Therapies, Inc.TSHA

——

Scholar RockSRRK

——

Praxis Precision Medicines, Inc.PRAX

——

Other financials

Income statement

See full

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

See full

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

See full

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

See full

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

See full

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

See full

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CalAmp's operating lease right-of-use asset amortization?: CalAmp (CAMP) reported operating lease right-of-use asset amortization of $34K in Q1 2026.
How has CalAmp's operating lease right-of-use asset amortization changed year-over-year?: CalAmp's operating lease right-of-use asset amortization decreased by 92.8% year-over-year, from $475K to $34K.